EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiomyopathy Screening Adherence Among Medicaid‐Enrolled Long‐Term Survivors of Childhood Cancer

Xin Hu iD, Sharon M Castellino, Deo Kumar Srivastava, Paul C Nathan, Gregory T Armstrong, Claire Snyder, Anne C Kirchhoff, Xu Ji iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.71116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Xin Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Medicaid, Cancer Survivors, Cardiomyopathies, Guideline Adherence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, CDC HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Childhood cancer survivors face increased risks of adverse cardiovascular outcomes due to treatment exposures. National guidelines recommend periodic cardiomyopathy screening for survivors exposed to anthracyclines or radiation. We examined the receipt of and the adherence to guideline‐recommended cardiomyopathy testing (echocardiogram, multigated acquisition scan, magnetic resonance imaging) among Medicaid‐enrolled childhood cancer survivors.

Method

Using data from the Childhood Cancer Survivor Study linked to administrative Medicaid claims, we analyzed 1062 at‐risk survivors aged 18–64 years who were continuously enrolled in Medicaid each year throughout 2015–2019.

Results

We found that 26.8% received any cardiomyopathy test, and 9.6% adhered to guidelines. Residence in Medicaid expansion (vs. non‐expansion) states was associated with 6.9% points (95% CI = 0.7–13.1) higher likelihood of receiving any cardiomyopathy test and 4.2% points (95% CI = 0.4–7.9) higher likelihood of adherence.

Conclusions

These findings suggest low receipt and poor adherence to guideline‐recommended cardiomyopathy screening among long‐term survivors of childhood cancer. Our data further underscore the critical role of Medicaid programs in supporting access to quality survivorship care for this vulnerable population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicaidCancer SurvivorsCardiomyopathiesGuideline AdherenceNeoplasmsMass ScreeningHumansMaleAdultFemaleAdolescentUnited StatesYoung AdultMiddle AgedAnthracyclines

Substanzen

Anthracyclines

Autor:innen und Institutionen

  • Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
  • Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Biostatistics Department, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Xin Hu, Xu Ji

Förderung

  • NCI NIH HHS
  • CDC HHS
  • NIH HHS
  • NIMHD NIH HHS
  • National Institutes of Health
  • Centers for Disease Control and Prevention

Zitieren

APA

Hu, X., Castellino, S. M., Srivastava, D. K., Nathan, P. C., Armstrong, G. T., Snyder, C., Kirchhoff, A. C., & Ji, X. (2025). Cardiomyopathy Screening Adherence Among Medicaid‐Enrolled Long‐Term Survivors of Childhood Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.71116

Vancouver

Hu X, Castellino SM, Srivastava DK, Nathan PC, Armstrong GT, Snyder C, et al. Cardiomyopathy Screening Adherence Among Medicaid‐Enrolled Long‐Term Survivors of Childhood Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.71116

BibTeX
@article{Hu2025,
  author = {Hu, Xin and Castellino, Sharon M and Srivastava, Deo Kumar and Nathan, Paul C and Armstrong, Gregory T and Snyder, Claire and Kirchhoff, Anne C and Ji, Xu},
  title = {Cardiomyopathy Screening Adherence Among Medicaid‐Enrolled Long‐Term Survivors of Childhood Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71116}
}
Kostenlos starten →